Previous Article | Next Article ![]()
J. Virol., Sep 1996, 6502-6507, Vol 70, No. 9
A Ehret, MO Westendorp, I Herr, KM Debatin, JL Heeney, R Frank and PH Krammer
CD4+ T-cell depletion in AIDS patients involves induction of apoptosis in
human immunodeficiency virus (HIV)-infected and noninfected T cells. The
HIV type 1 (HIV-1)-transactivating protein Tat enhances apoptosis and
activation-induced cell death (AICD) of human T cells. This effect is
mediated by the CD95 (APO-1/Fas) receptor-CD95 ligand (CD95L) system and
may be linked to the induction of oxidative stress by Tat. Here we show
that HIV-1 Tat-induced oxidative stress is necessary for sensitized AICD in
T cells caused by CD95L expression. Tat-enhanced apoptosis and CD95L
expression in T cells are inhibited by neutralizing anti-Tat antibodies,
antioxidants, and the Tat inhibitor Ro24-7429. Chimpanzees infected with
HIV-1 show viral replication resembling early infection in humans but do
not show T-cell depletion or progression towards AIDS. The cause for this
discrepancy is unknown. Here we show that unlike Tat-treated T cells in
humans, Tat-treated chimpanzee T cells do not show downregulation of
manganese superoxide dismutase or signs of oxidative stress. Chimpanzee T
cells are also resistant to Tat- enhanced apoptosis, AICD, and CD95L
upregulation.
Copyright © 1996, American Society for Microbiology
Resistance of chimpanzee T cells to human immunodeficiency virus type 1 Tat-enhanced oxidative stress and apoptosis
Tumor Immunology Program, German Cancer Research Center, Heidelberg, Germany.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»